181 related articles for article (PubMed ID: 15217318)
1. Detection of IL-13, IL-10, and IL-6 in the leprosy skin lesions of patients during prednisolone treatment for type 1 (T1R) reactions.
Atkinson SE; Khanolkar-Young S; Marlowe S; Jain S; Reddy RG; Suneetha S; Lockwood DN
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):27-34. PubMed ID: 15217318
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India.
Lockwood DN; Vinayakumar S; Stanley JN; McAdam KP; Colston MJ
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):8-15. PubMed ID: 8326184
[TBL] [Abstract][Full Text] [Related]
3. Reactions in borderline leprosy.
Ramu G; Desikan KV
Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal.
Marlowe SN; Hawksworth RA; Butlin CR; Nicholls PG; Lockwood DN
Trans R Soc Trop Med Hyg; 2004 Oct; 98(10):602-9. PubMed ID: 15289097
[TBL] [Abstract][Full Text] [Related]
5. Histopathological study of apparently normal skin of patients with leprosy.
El-Darouti MA; Hussein S; Marzouk SA; Nabil N; Hunter NS; Mahgoub D; El-Eishi NH; Abdel-Halim MR
Int J Dermatol; 2006 Mar; 45(3):292-6. PubMed ID: 16533232
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
7. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the cortisol-cortisone shuttle in leprosy type 1 reactions in leprosy patients in Hyderabad, India.
Andersson AK; Atkinson SE; Khanolkar-Young S; Chaduvula M; Jain S; Suneetha L; Suneetha S; Lockwood DN
Immunol Lett; 2007 Mar; 109(1):72-5. PubMed ID: 17320974
[TBL] [Abstract][Full Text] [Related]
9. Contribution of type 1 reactions to sensory and motor function loss in borderline leprosy patients and the efficacy of treatment with prednisone.
Roche PW; Theuvenet WJ; Le Master JW; Butlin CR
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):340-7. PubMed ID: 9934360
[TBL] [Abstract][Full Text] [Related]
10. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report.
Kar HK; Raina A; Sharma PK; Bhardwaj M
Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077
[TBL] [Abstract][Full Text] [Related]
11. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
Santaram V; Porichha D
Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and management of leprosy reaction in China in 2005.
Shen J; Liu M; Zhou M; Wengzhong L
Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
[TBL] [Abstract][Full Text] [Related]
13. Relapse in leprosy after multidrug therapy and its differential diagnosis with reversal reaction.
Reddy PK; Cherian A
Indian J Lepr; 1991; 63(1):61-9. PubMed ID: 1919091
[TBL] [Abstract][Full Text] [Related]
14. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
Jain M; Singh N; Bhatia A; Arora VK
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
[TBL] [Abstract][Full Text] [Related]
15. Localized borderline lepromatous leprosy.
Arunthathi S; Samuel J; Ebenezer GJ; Jacob M
Indian J Lepr; 1995; 67(2):177-81. PubMed ID: 8537706
[No Abstract] [Full Text] [Related]
16. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions.
Rea TH
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):410-6. PubMed ID: 11332284
[TBL] [Abstract][Full Text] [Related]
17. Inside the skin: the local immune and inflammatory milieu in leprosy.
Scollard DM
Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):17-23. PubMed ID: 2042708
[TBL] [Abstract][Full Text] [Related]
18. Leprosy reactions. New knowledge.
Naafs B
Trop Geogr Med; 1994; 46(2):80-4. PubMed ID: 8079395
[No Abstract] [Full Text] [Related]
19. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Armour KS; Scolyer RA; Barnetson RS
Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
[TBL] [Abstract][Full Text] [Related]
20. Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy.
Goulart IM; Figueiredo F; Coimbra T; Foss NT
Am J Pathol; 1996 Mar; 148(3):911-7. PubMed ID: 8774145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
